Sunshine Biopharma (SBFM) Net Equity Issued and Repurchased (2010 - 2024)
Sunshine Biopharma's (SBFM) quarterly Net Equity Issued and Repurchased came in at $8.5 million in Q1 2024, up 85224010.0% on a QoQ basis from $10.0 in Q3 2023.
Sunshine Biopharma (SBFM) Net Equity Issued and Repurchased (2010 - 2024) Analysis & Trends
Sunshine Biopharma (SBFM) has 10 years of Net Equity Issued and Repurchased data on file, last reported at $8.5 million in Q1 2024.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $8.5 million in Q1 2024, while the trailing twelve-month figure through Dec 2024 was $8.5 million (up 108.41% YoY) and the FY2025 annual result came in at $1.8 million, down 78.54% from the prior year.
- Net Equity Issued and Repurchased rose to $8.5 million in Q1 2024, from $10.0 in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $29.1 million in Q2 2022 to a low of -$13.2 million in Q4 2022.
- A 3-year average of $7.2 million and a median of $6.3 million in 2023 frame the typical range for Net Equity Issued and Repurchased.
- The widest YoY moves for Net Equity Issued and Repurchased: up 85.96% in 2023, down 85.96% in 2023.
- Tracing SBFM's Net Equity Issued and Repurchased over 3 years: stood at -$13.2 million in 2022, then surged by 100.0% to $10.0 in 2023, then soared by 85224010.0% to $8.5 million in 2024.
- The last three Net Equity Issued and Repurchased figures came in at $8.5 million (Q1 2024), $10.0 (Q3 2023), and $4.1 million (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Sunshine Biopharma | 1.58 Mn | -12.17 Mn | 2.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 8.52 Mn |
| Mar 31, 2024 | 8.52 Mn |
| Sep 30, 2023 | 10.00 |
| Sep 30, 2023 | 10.00 |
| Jun 30, 2023 | 4.09 Mn |
| Jun 30, 2023 | 4.09 Mn |
| Dec 31, 2022 | -13.19 Mn |
| Dec 31, 2022 | -13.19 Mn |
| Jun 30, 2022 | 29.12 Mn |
| Jun 30, 2022 | 29.12 Mn |
| Mar 31, 2022 | 14.44 Mn |
| Mar 31, 2022 | 14.44 Mn |
| Jun 30, 2017 | 63,912.00 |
| Jun 30, 2017 | 63,912.00 |
| Jun 30, 2016 | 25,000.00 |
| Jun 30, 2016 | 25,000.00 |
| Mar 31, 2016 | 79,128.00 |
| Mar 31, 2016 | 79,128.00 |
| Jun 30, 2015 | 118,275.00 |
| Jun 30, 2015 | 118,275.00 |